EUVIMEDEUVIMED entdecken
Crossref

Establishment and characterization of the novel myxofibrosarcoma cell line, SMU-MFS

Naoya Nakahashi, Makoto Emori, Kohichi Takada, Yasutaka Murahashi, Junya Shimizu, Kazuyuki Murase, Tomohide Tsukahara, Shintaro Sugita, Akira Takasawa, Kousuke Iba, Atsushi Teramoto, Makoto Osanai

Human Cell · 2024

DOI: 10.1007/s13577-024-01157-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Cell, 2024. Verfasst von Naoya Nakahashi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine, West 16, South 1, Chuo-ku, Sapporo, 060-8543, Japan. Hauptthemen laut MEDLINE: Fibrosarcoma, Pyrimidines. Die Arbeit nennt 42 Literaturangaben. Gefördert von: JSPS KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myxofibrosarcoma (MFS) is one of the most common soft-tissue sarcomas in elderly patients. Owing to the limited efficacy of chemotherapy and radiotherapy, complete resection is the only available curative treatment. Therefore, developing novel therapies for MFS is important to improve clinical outcomes. Herein, a novel MFS cell line, namely SMU-MFS, was established to better understand the biologic characteristics of MFS and develop new therapies. A tissue sample from the surgically resected tumor tissue of a 56-year-old patient with a tumor was subjected to primary culture. The cell line was established and authenticated by assessing the short tandem repeats of DNA microsatellites. The monolayer cultures of SMU-MFS cells exhibited constant growth, spheroid formation, and invasive capacity. Furthermore, the cells exhibited low chemosensitivity to doxorubicin, eribulin, and pazopanib, which are used to inhibit metastatic progression. In addition, of the four mice inoculated with SMU-MFS cells, tumors developed in two mice after 8 weeks. Altogether, the findings of this study suggest that the SMU-MFS cell line can be a useful tool for investigating MFS development and evaluating novel therapeutic agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FibrosarcomaPyrimidinesHumansMiddle AgedCell Line, TumorAnimalsDoxorubicinFuransKetonesSulfonamidesIndazolesMiceAntineoplastic AgentsMalePolyether Polyketides

Stichwörter der Autor:innen

Cell lineChemotherapyLocal recurrenceMyxofibrosarcoma

Substanzen

PyrimidineseribulinDoxorubicinFuranspazopanibKetonesSulfonamidesIndazolesAntineoplastic AgentsPolyether Polyketides

Autor:innen und Institutionen

  • Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine, West 16, South 1, Chuo-ku, Sapporo, 060-8543, Japan.
  • Departments of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine, West 16, South 1, Chuo-ku, Sapporo, 060-8543, Japan. emrmkt@yahoo.co.jp.
  • Department of Medical Oncology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Department of Surgical Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Division of Tumor Pathology, Department of Pathology, Asahikawa Medical University School of Medicine, Asahikawa, Japan.

Förderung

  • JSPS KAKENHI

Zitieren

APA

Nakahashi, N., Emori, M., Takada, K., Murahashi, Y., Shimizu, J., Murase, K., Tsukahara, T., Sugita, S., Takasawa, A., Iba, K., Teramoto, A., & Osanai, M. (2024). Establishment and characterization of the novel myxofibrosarcoma cell line, SMU-MFS. Human Cell. https://doi.org/10.1007/s13577-024-01157-9

Vancouver

Nakahashi N, Emori M, Takada K, Murahashi Y, Shimizu J, Murase K, et al. Establishment and characterization of the novel myxofibrosarcoma cell line, SMU-MFS. Human Cell. 2024. doi:10.1007/s13577-024-01157-9

BibTeX
@article{Nakahashi2024,
  author = {Nakahashi, Naoya and Emori, Makoto and Takada, Kohichi and Murahashi, Yasutaka and Shimizu, Junya and Murase, Kazuyuki and Tsukahara, Tomohide and Sugita, Shintaro and Takasawa, Akira and Iba, Kousuke and Teramoto, Atsushi and Osanai, Makoto},
  title = {Establishment and characterization of the novel myxofibrosarcoma cell line, SMU-MFS},
  journal = {Human Cell},
  year = {2024},
  doi = {10.1007/s13577-024-01157-9}
}
Kostenlos starten →